from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1502/-

LFCtreatmentdescriptionclass of inhibitor

-2.741

Amikacinug/mL Amikacintranslation

-1.108

Cap5-10ug/mL Capreomycintranslation

-1.779

Rox10-50 ug/mL Roxithromycintranslation

-0.714

SM2-5 ug/mL Streptomycintranslation

-2.152

Tet5-10 ug/mL Tetracyclinetranslation

-0.045

Rif0.2-5ug/mL Rifampicintranscription

-0.131

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.838

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.409

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.548

CPZ10-50 ug/mL Chlorpromazinerespiration

1.398

Clofazimine10-13 ug/mL Clofaziminerespiration

0.995

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.058

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.174

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.002

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.033

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.628

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.556

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.947

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.559

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.076

KCN5-20 ug/mL Potassium cyaniderespiration

0.683

NaN30.2-2 mM Sodium aziderespiration

-0.099

Nigericin50 uM Nigericinrespiration

-1.465

TRC10-150 ug/mL Triclosanrespiration

-1.011

TRZ10-25 ug/mL Thioridazinerespiration

-1.719

Valinomycin0.5-10 uM Valinomycinrespiration

0.414

ZnSO42 mM ZnSO4respiration

-1.415

menadione6-10 ug/mL Menadionerespiration

0.189

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.125

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.010

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.324

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.802

NRP_1Non-replicating persistence stage 1dosRassociated

0.393

Amp0.2mg/mL AmpicillincellWall

0.185

Cephalexin20-100 ug/mL CephalexincellWall

-0.124

Cerulenin0.32-5 ug/mL CerulenincellWall

0.835

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.332

EMB10-20 ug/mL EthambutolcellWall

-0.087

Eta12-40 ug/mL EthionamidecellWall

-0.040

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.014

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.388

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.170

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.544

BZA0.12 mg/mL BenzamidearomaticAmides

-0.013

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.251

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.455

H2O24 mM hydrogen peroxideDNAdamaging

0.142

Levo10 ug/mL LevofloxacinDNAdamaging

0.675

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

2.563

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.272

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.728

UVUV-irradiationDNAdamaging

-1.689

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.098

Antimycin12.5-50 ug/mL Antimycin A?

0.482

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.403

PA_110-50 ug/mL Antitubercular compound PA-1?

0.482

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.367

PA8240.2-2 ug/mL PA-824?

-0.046

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.184

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.272

Verapamil50 uM Verapamil?

-0.072

mercaptoethanol2 mM 2-Mercaptoethanol?

0.533

methoxatin10-20 ug/mL Methoxatin?